San Francisco, CACIK 15600094 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
7 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Monte Rosa Therapeutics Inc | 4.38M | $68.72M | 45.5% | −1.27M | Reduced |
| 2 | Lenz Therapeutics Inc | 2.66M | $42.51M | 28.1% | 0 | Held |
| 3 | Jade Biosciences Inc | 1.53M | $23.54M | 15.6% | 0 | Held |
| 4 |
| 148.8K |
| $7.80M |
| 5.2% |
| 0 |
| Held |
| 5 | Contineum Therapeutics Inc | 542.6K | $6.20M | 4.1% | 0 | Held |
| 6 | Skye Bioscience Inc | 2.01M | $1.51M | 1.0% | 0 | Held |
| 7 | Tempest Therapeutics Inc | 269.8K | $774.2K | 0.5% | 0 | Held |